Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) Stock Rated “Moderate Buy” by Sell-Side Analysts

Reckitt Benckiser Group PLC (OTCMKTS:RBGLY – Get Free Report) has received an average recommendation of “Moderate Buy” from the ten analysts that are presently covering the stock, MarketBeat.com reports. Four analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and two have assigned a strong buy recommendation to the company.

A number of brokerages recently commented on RBGLY. The Goldman Sachs Group raised shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research note on Wednesday, October 7th. Jefferies Financial Group upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research report on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Reckitt Benckiser Group in a research report on Tuesday, June 30th. BNP Paribas Exane downgraded shares of Reckitt Benckiser Group from an “outperform” rating to a “neutral” rating in a report on Wednesday, September 2nd. Finally, Zacks Research upgraded shares of Reckitt Benckiser Group from a “strong sell” rating to a “hold” rating in a research report on Friday, August 28th.

Check Out Our Latest Stock Analysis on Reckitt Benckiser Group

Reckitt Benckiser Group Stock Performance

Shares of RBGLY opened at $14.31 on Thursday. The company has a current ratio of 0.59, a quick ratio of 0.40 and a debt-to-equity ratio of 1.31. Reckitt Benckiser Group has a 52-week low of $12.02 and a 52-week high of $17.80. The company has a 50-day simple moving average of $13.77 and a 200-day simple moving average of $13.39.

About Reckitt Benckiser Group

(Get Free Report)

Reckitt Benckiser Group plc, now known as Reckitt, is a United Kingdom-based consumer health and hygiene company headquartered in Slough, England. The company develops, manufactures and markets products intended to support personal health, household cleanliness and hygiene.

Its brand portfolio includes consumer health products such as Nurofen, Strepsils, Mucinex and Durex, as well as household and hygiene brands including Dettol, Lysol, Finish and Vanish. Reckitt’s products are sold through retailers, pharmacies, e-commerce platforms and other distribution channels.

The company was formed in 1999 through the merger of Reckitt & Colman and Benckiser.

Recommended Stories

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.